Key result
Cancer and aggressive therapies drive arterial and venous thrombosis via inflammation and endothelial damage.
Answers are grounded in this paper and cite their sources.
Reveals the connections between cancer and thrombosis, suggesting significant implications for patient management.
Thrombosis was identified as a complication of cancer by Trousseau in 1865, and the combination of the two conditions is still often called Trousseau's syndrome. Arterial and, more commonly, venous thrombosis is a frequent complication of cancer and sometimes a harbinger of occult cancer. Moreover, the use of new and aggressive therapy for cancer increases the risk of thrombosis.There are many causes of thrombosis in cancer. Cancer itself is often the underlying mechanism. When cells of the monocyte or macrophage lineage interact with malignant cells, they release tumor necrosis factor, interleukin-1, and interleukin-6, causing endothelial damage and sloughing of . . .
No takes yet. Share an insight, caveat, or question.
Rodger L. Bick (2003) conducted a review in Cancer-Associated Thrombosis. Cancer and cancer therapy was evaluated. Cancer and aggressive cancer therapies act as underlying mechanisms for arterial and venous thrombosis through the release of inflammatory cytokines and endothelial damage.
Synapse has enriched 10 related papers. Consider them for comparative context: